Menstrual Migraines are More Severe, Last Longer and are More Resistant to Treatment
March 12th, 2017
DON’T LET YOUR MENSTRUAL MIGRAINES BECOME CHRONIC MIGRAINES
Menstrual migraines are difficult to control. Approximately 1 in 7 adults have migraines, but women are three times more likely to be affected than men and 60% to 70% report a menstrual relationship to their migraine attacks. Menstrual related migraine attacks are often more severe, last significantly longer, and are more resistant to treatment than the usual non-menstrual migraine attacks.
Menstrual migraines that occur only monthly can progress into chronic migraines. Researchers are discovering that migraines beget migraines, the more you have the more you will tend to get.
According to a study published in the medical journal, Cephalalgia:
- > On average, a menstrual migraine lasted 23.4 hours vs 16.1 hours for non-menstrual migraines.
- > Menstrual migraines cause more disability and inability to function in daily tasks than non-menstrual migraines
- > Medications to treat the pain of migraines were 50% less effective when used to treat menstrual migraines.
- > Even when the pain medication did work, the risk of the menstrual migraine reoccurring was much more likely.
The authors of the study concluded by saying – “Menstrual migraines may require a treatment approach different from that of non-menstrual migraines.”
Other literature indicates only 13.5% of sufferers are pain-free after 2 hours compared to 32.9% of non-menstrual migraine attacks. This indicates that 86.5% of menstrual migraine sufferers and 67.1% of non-menstrual migraine sufferers do not achieve complete relief from debilitating migraine pain after 2 hours.
The “Terrible Twosome” of Hormonal Fluctuations and Insulin Resistance Can Wreak Havoc on a Woman’s Over-All Health and Cause Symptoms of PMS, PCOS and Menstrual Migraines
Insulin resistance is the body’s inability to respond well to insulin, which controls blood sugar levels and can lead to Type II diabetes, abdominal weight gain and migraines. High insulin levels due to insulin resistance increase the production of the male hormone, testosterone. High testosterone levels cause symptoms such as body hair growth, acne, irregular periods and weight gain (all of these are PCOS symptoms).
There is a Direct Relationship between Hormones and Migraines
Headaches in women, particularly migraines, have been related to changes in the levels of the female hormones estrogen and progesterone before, during and after a woman’s menstrual cycle. Estrogen, progesterone and even testosterone levels can fluctuate significantly a few days before and after menstruation leading to migraines and causing symptoms of PMS (Premenstrual Syndrome) and PCOS (Polycystic Ovary Syndrome) such as:
PMS Symptoms:
- » Menstrual migraines
- » Anxiety
- » Overeating
- » Breast Swelling
- » Weight Gain
- » Bloating
- » Irritability & Mood Swings|
- » Abdominal and Pelvic Cramps
- » Fatigue
- » Headaches
- » Changes in Libido
- » Depression
- » Insomnia
- » Acne
- » Hives
PCOS Symptoms:
- » Hair loss: similar to male pattern baldness
- » Obesity and inability to lose weight
- » Acne
MigreLief+M and Menstrual Migraines
In addition to the 3 ingredients in Original MigreLief, drug-free MigreLief+M contains 5 additional ingredients that have been shown to not only balance blood sugar swings and the hormonal fluctuations that lead to menstrual migraines, but to also significantly decrease PMS pre-menstrual and PCOS symptoms.
Ingredients:
Riboflavin (Vitamin B-2, 400 mg/day)*
Puracol Feverfew (100 mg/day)*
Magnesium (citrate/oxide, 360mg/day)*
Chasteberry extract (175 mg/day)
L-Theanine (100 mg/day)
D-Biotin (15 mg/day)
Pyridoxine Hydrochloride (vitamin B-6, 100 mg/day)
Chromium Picolinate
*Riboflavin, feverfew and magnesium are listed in the American Academy of Neurology’s Guidelines for Migraine Prevention (Detailed Ingredients Description)
MENOPAUSE & MIGRAINES
Migraine headaches can severely affect women undergoing the changes of menopause. Statistics indicate that migraines in women tend to increase during the approach to menopause and during menopause; however, they tend to decrease or go away after menopause.
Some women who have never had migraines develop them as they enter the period before (pre and peri-menopause) and during menopause.
MigreLief Making a Difference
Until MigreLief+M, no one product was available to address both hormonal and blood sugar fluctuation, migraines and other symptoms associated with a woman’s hormones or menstrual cycle.
Try MigreLief+M today!
To the Best of Health,
Curt Hendrix, M.S., C.C.N., C.N.S.
Chief Scientific Officer, Akeso Health Sciences
Makers of MigreLief.com